ASP-2905 is a brain-penetrant, selective Kv12.2 (Kcnh3) potassium channel inhibitor with demonstrated antipsychotic activity in preclinical models. This small molecule is a valuable research tool for investigating CNS pharmacology, neuropsychiatric disorders, and ion channel function in both in vitro and in vivo studies.